Dosage reduction and discontinuation of biological disease-modifying antirheumatic drugs in patients with rheumatoid arthritis, psoriatic arthritis and axial spondyloarthritis: protocol for a pragmatic, randomised controlled trial (the BIOlogical Dose OPTimisation (BIODOPT) trial)

Line Uhrenholt, Annette Schlemmer, Ellen-Margrethe Hauge, Robin Christensen, Lene Dreyer, Maria E Suarez-Almazor, Salome Kristensen

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

3 Citationer (Scopus)
22 Downloads (Pure)

Fingeraftryk

Dyk ned i forskningsemnerne om 'Dosage reduction and discontinuation of biological disease-modifying antirheumatic drugs in patients with rheumatoid arthritis, psoriatic arthritis and axial spondyloarthritis: protocol for a pragmatic, randomised controlled trial (the BIOlogical Dose OPTimisation (BIODOPT) trial)'. Sammen danner de et unikt fingeraftryk.

Citationsformater